Fresenius Medical cuts top end of 2026 profit outlook

Impact · against what's priced in

Fresenius Medical's downward revision of its 2026 profit outlook suggests a deterioration in long-term earnings growth expectations. This reduction in the upper-end profit target likely forces a downward adjustment of EPS estimates for the coming years.

FME−0.40

No priced-in read yet

In context

The company has lowered the top end of its profit outlook for 2026, indicating a negative shift in forward earnings expectations.

Read from the article alone

• healthcare
• guidance
• FME
• medical devices
• profit warning

Search tags